These were the worst performing ASX 200 shares in December

These ASX 200 shares had a tough month…

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

December certainly was a great month for the S&P/ASX 200 Index (ASX: XJO). The benchmark index rose 2.6% over the period to end it at 7,444.6 points.

Unfortunately, not all shares were able to climb higher with the market. Here's why these were the worst performing ASX 200 shares in December:

ASX shares downgrade A young woman with tattoos puts both thumbs down and scrunches her face with the bad news.

Image source: Getty Images

Magellan Financial Group Ltd (ASX: MFG)

The Magellan share price was the worst performer on the ASX 200 last month with a 34.4% decline. Investors were selling off the fund manager's shares after it announced the termination of the St James's Place mandate. Magellan advised that the mandate represents approximately 12% of the company's current annual revenues. Though, due to the timing of its termination, it is only anticipated to impact Magellan's FY 2022 revenues by 6%. Investors appear concerned more mandates could be lost, particularly given the very poor performance of its flagship fund.

Afterpay Ltd (ASX: APT)

The Afterpay share price was some way behind as the next worst performer with a decline of 17%. The buy now pay later (BNPL) provider's shares were sold down after the Square share price tumbled lower. As Afterpay shareholders have voted in favour of being acquired by Square in an all-scrip deal, its shares rise and fall with the Square share price.

Mesoblast Limited (ASX: MSB)

The Mesoblast share price was a poor performer and dropped 12.7% during the month. Investors were selling off the allogeneic cellular medicines developer's shares after Novartis terminated an agreement that could have been worth ~US$1.2 billion. The two parties were looking at Mesoblasts' remestemcel-L as a treatment for acute respiratory distress syndrome (ARDS) due to COVID-19. Novartis ended the agreement after reviewing some disappointing trial results.

Zip Co Ltd (ASX: Z1P)

The Zip share price was out of form again and dropped 11.5% last month. This was driven by weakness in the tech sector and concerns over news that US authorities are launching an investigation into the BNPL sector. The US Consumer Financial Protection Bureau is looking to see if BNPL players need to be better regulated and if US consumers are adequately protected.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns and has recommended Afterpay Limited and ZIPCOLTD FPO. The Motley Fool Australia owns and has recommended Afterpay Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Fallers

A businesswoman pulls her glasses down in shock to look at the bad news on her computer.
Share Fallers

Why Bank of Queensland, Brainchip, Pilbara Minerals, and Yancoal shares are sinking today

These ASX shares are being hammered on Tuesday.

Read more »

a middle-aged woman holds up two fingers with a wide mouthed smile on her face and wide open eyes.
Share Fallers

'Top quality': Expert picks 2 ASX 200 shares to buy at a nice discount

These stocks are down but not out. One portfolio manager is convinced they'll make you richer in the long run.

Read more »

a group of business people sit dejectedly around a table, each expressing desolation, sadness and disappointment by holding their head in their hands, casting their gazes down and looking very glum.
Share Fallers

Why Atlantic Lithium, Arafura, Brainchip, and Core Lithium shares are falling

These ASX shares are starting the week in the red.

Read more »

A woman with a sad face looks to be receiving bad news on her phone as she holds it in her hands and looks down at it.
Share Fallers

Why Atlantic Lithium, CBA, Piedmont Lithium, and Pilbara Minerals shares are dropping

These ASX shares are ending the week deep in the red.

Read more »

Woman looking at her smartphone and analysing share price.
Share Fallers

Golden buying opportunity for 2 ASX shares slashed last month: Celeste

Here's a pair of businesses that are going pretty strong but whose stock prices are in a dip, ready now…

Read more »

A man sits in despair at his computer with his hands either side of his head, staring into the screen with a pained and anguished look on his face, in a home office setting.
Share Fallers

Why 29Metals, BHP, Helia, and Rio Tinto shares are dropping today

Here's why these ASX shares are weighing on the market's performance on Thursday.

Read more »

a woman holds her hands to her temples as she sits in front of a computer screen with a concerned look on her face.
Share Fallers

Why Nuix, Smartgroup, Ventia, and Woodside shares are dropping today

These ASX shares are having a tough time on the ASX boards on Wednesday.

Read more »

A woman looks distressed as she stares dramatically at her phone
Share Fallers

Why Brainchip, Lynas, Megaport, and Universal Store shares are dropping today

These ASX shares are having a tough time on Tuesday.

Read more »